How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,009 results for

Spondyloarthropathy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future (PubMed)

The Management of Acute Anterior Uveitis Complicating Spondyloarthritis: Present and Future Spondyloarthropathies (SpA) encompass a group of chronic inflammatory diseases sharing common genetic and clinical features, including the association with HLA-B27 antigen, the involvement of both the axial and the peripheral skeleton, the presence of dactylitis, enthesitis, and typical extra-articular manifestations such as psoriasis, inflammatory bowel disease, and acute anterior uveitis (AAU

Full Text available with Trip Pro

2018 BioMed research international

162. Current evidence for spinal X-ray use in the chiropractic profession: a narrative review (PubMed)

, with consideration of the related risks and benefits. Current evidence supports the use of spinal X-rays only in the diagnosis of trauma and spondyloarthropathy, and in the assessment of progressive spinal structural deformities such as adolescent idiopathic scoliosis. MRI is indicated to diagnose serious pathology such as cancer or infection, and to assess the need for surgical management in radiculopathy and spinal stenosis. Strong evidence demonstrates risks of imaging such as excessive radiation exposure

Full Text available with Trip Pro

2018 Chiropractic & manual therapies

163. An unexpected cause of sacroiliitis in a patient with gout and chronic psoriasis with inflammatory arthritis: a case report. (PubMed)

An unexpected cause of sacroiliitis in a patient with gout and chronic psoriasis with inflammatory arthritis: a case report. Inflammatory back pain is a condition characterized by inflammation of the sacroiliac joints and lower spine. It is frequently seen in patients with spondyloarthropathies like ankylosing spondylitis, psoriatic arthritis, enteropathic arthritis and reactive arthritis. Inflammatory back pain can be caused by many other conditions like infection and crystal deposition (...) such as gout. In this case, it is difficult to specifically identify gout as a cause by ordinary imaging like magnetic resonance imaging (MRI) or ultrasound.This case report describes a young man with severe psoriasis, presumptive psoriatic spondyloarthropathy and chronic extensive tophaceous gout which was difficult to treat because of non-compliance with medications and lifestyle. He presented with inflammatory type low back and buttocks pain with raised inflammatory markers. MRI of the lower back

Full Text available with Trip Pro

2018 BMC Musculoskeletal Disorders

164. Effects of Aerobic Training in Patients with Ankylosing Spondylitis (PubMed)

were the Bath indexes [Bath AS Functional Index (BASFI), Bath AS Disease Activity Index (BASDAI), and Bath AS Metrology Index (BASMI)], Health Assessment Questionnaire for the Spondyloarthropathies (HAQ-S), AS Disease Activity Score (ASDAS), the 6-min walk test (6MWT), chest expansion, and the Medical Outcomes Study Short Form-36. Aerobic capacity was assessed by ergospirometry on a treadmill. Routine laboratory techniques were used in determining lipid levels. Assessments were performed

2016 EvidenceUpdates

165. Efficacy and Safety of a Intra-articular Injection, ENKO1, in Patients With Symptomatic Knee Osteoarthritis.

randomisation. Paget's disease of bone, chondromatosis or villonodular sinovitis. Inflammatory, infectious or metabolic arthritis (rheumatoid arthritis, spondyloarthropathy or connective tissue diseases). Haemochromatosis, ochronosis or haemophilia. History of diseases that the investigator considers likely to interfere with the functional disability assessment. Knee surgery planned during the study period. Other disease-related criteria: BMI greater than or equal to 30. Immunodeficiency or a serious

2018 Clinical Trials

166. Upright Back Posture Device Study

disc, lumbar spondylolysis, radiculitis, facet arthrosis, fibromyalgia, rheumatoid arthritis, seronegative spondyloarthropathy. Neurologic deficits on exam Currently in physical therapy (PT) Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03769246

2018 Clinical Trials

167. A systematic evaluation of the therapeutic effectiveness of sacroiliac joint interventions

to be at least one month. Eligible patients were adults (at least 18 years old) with chronic low back and/or lower extremity pain which had lasted for at least three months and for whom other therapies had not worked. The primary outcome of interest was pain relief. Secondary outcomes were functional improvement, change in psychological status, return to work, reduction or elimination of opioid use/other interventions, and complications. Studies of spondyloarthropathy were excluded. Further inclusion

2012 DARE.

168. Dietary Supplement for Joint: the OLE Study

synovitis of the knee, seronegative spondyloarthropathy, rheumatoid arthritis, gouty arthritis , infectious arthritis, radiculalgia in the lower limbs, arteritis Prosthesis in the target knee Diagnosed arthrosis eligible to knee/joint surgery/replacement Related to treatments Analgesics to manage knee pain 24h before inclusion visit Corticosteroids injection in the target knee in the month preceding inclusion Hyaluronan injection in the target knee in the last 6 months Oral corticotherapy ≥ 5mg/day

2017 Clinical Trials

169. The SpACE Study

The SpACE Study The SpACE Study - Small Bowel Crohn's Disease and Spondyloarthropathies - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. The SpACE Study - Small Bowel Crohn's Disease (...) and Spondyloarthropathies (SpACE) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03064815 Recruitment Status : Completed First Posted : February 27, 2017 Last Update Posted : March 1, 2017 Sponsor: McGill University Health Center Collaborators: AbbVie Prometheus Laboratories Information provided by (Responsible Party

2017 Clinical Trials

170. Cartography and Quantitative Characterization of Achilles Tendon Fibrocartilage by TE = 0ms Imaging at 3T MRI

enthesis study using the calcaneal tendon as a clinical model Condition or disease Intervention/treatment Phase Spondyloarthropathy Tendinopathy Device: MRI ZTE2 sequence Not Applicable Detailed Description: The human body contains a lot of tissue components with short T2 (transversal relaxation time) that are not or only poorly detected on conventional T2-weighted MR sequences. These components are mostly located in musculoskeletal organs such as tendons, ligaments, menisci, periosteum or cortical (...) bone. Considering that conventional sequences do not detect tissue components with T2 shorter than 10ms, imaging of body tendon or enthesis is therefore very limited. This represents a limitation of MR imaging in early diagnosis of a certain number of pathologies, such as mechanical or mostly inflammatory tendinopathy or enthesopathy. This study, would provide the feasibility of ZTE 2 sequence to quantitatively assess normal and pathological spondyloarthropathy Achilles tendon enthesis at 3 T

2017 Clinical Trials

171. Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis. (PubMed)

PsC. This amino acid also represents the largest genetic effect for ankylosing spondylitis, thereby refining the genetic overlap of these two spondyloarthropathies. Correcting for bias has important implications for cross-phenotype genetic studies.© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Full Text available with Trip Pro

2017 Annals of the Rheumatic Diseases

172. Hip resurfacing arthroplasty for patients with inflammatory arthritis: a systematic review. (PubMed)

in these series, however, their outcomes following resurfacing are underreported. The aim of this study was to determine complications that may occur following hip resurfacing in patients with inflammatory arthritis. A secondary aim was to determine functional outcomes following resurfacing.A search was performed in MEDLINE (PubMed/OVID), Cochrane Library, and Google Scholar. 5 studies met eligibility criteria. This review includes 196 hips; 120 had a diagnosis of AS or seronegative spondyloarthropathy and 76

2017 Hip international : the journal of clinical and experimental research on hip pathology and therapy

173. Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis. (PubMed)

Serologic Evidence of Gut-driven Systemic Inflammation in Juvenile Idiopathic Arthritis. Accumulating evidence links juvenile idiopathic arthritis (JIA) to nonhost factors such as gut microbes. We hypothesize that children with new-onset JIA have increased intestinal bacterial translocation and circulating lipopolysaccharide (LPS).We studied systemic treatment-naive patients with JIA [polyarticular JIA, n = 22, oligoarticular JIA, n = 31, and spondyloarthropathies (SpA), n = 16], patients

Full Text available with Trip Pro

2017 Journal of Rheumatology

174. Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis. (PubMed)

Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis. To assess the impact of switching tumor necrosis factor (TNF)-alpha inhibitors on patients with axial spondyloarthritis (axSpA).PubMed literature searches were conducted using combinations of search terms including ankylosing spondylitis, spondyloarthropathy, spondyloarthritis, switch/switching, drug survival, and TNF/tumor necrosis factor to identify published articles with data on outcomes related

Full Text available with Trip Pro

2017 Seminars in arthritis and rheumatism

175. Serum apoprotein A1 levels are inversely associated with disease activity in gout: From a southern Chinese Han population. (PubMed)

(AS)/spondyloarthropathy (SpA), and 25 patients with osteoarthritis (OA). The serum levels of apoprotein A1 (Apo-A1) were significantly decreased in patients with gout when compared with RA, AS/SpA, and OA patients. The serum levels of CRP were significantly increased in gouty patients when compared with RA, AS/SpA, and OA patients. Furthermore, the serum levels of ESR were significantly increased in patients with gout compared to patients with OA. Correlation analysis indicated that the levels of Apo-A1 were

Full Text available with Trip Pro

2017 Medicine

176. Ankylosing Spondylitis Increases Perioperative and Postoperative Complications After Total Hip Arthroplasty. (PubMed)

Ankylosing Spondylitis Increases Perioperative and Postoperative Complications After Total Hip Arthroplasty. Ankylosing spondylitis (AS) is a chronic autoimmune spondyloarthropathy that primarily affects the axial spine and hips. Progressive disease leads to pronounced spinal kyphosis, positive sagittal balance, and altered biomechanics. The purpose of this study is to determine the complication profile of patients with AS undergoing total hip arthroplasty (THA).The Medicare sample was searched

2017 Journal of Arthroplasty

177. Familial Mediterranean fever patients with hidradenitis suppurativa. (PubMed)

characteristics of two unrelated patients with HS and familial Mediterranean fever (FMF).Case study.Besides FMF and HS, the first patient had acne conglobata, and the second patient had pyoderma gangrenosum and ankylosing spondyloarthropathy. Both patients had M694V/V726A MEFV gene mutations.PASH and PAPASH have recently been associated with genetic alterations of gene encoding proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1), which interacts with the product of MEFV gene

2017 International Journal of Dermatology

178. New developments in uveitis associated with HLA B27. (PubMed)

and some of the clinical implications of AAU. Progress has been made in the treatment of uveitis in general and in the treatment of uveitis in association with spondyloarthropathy in particular. The pathogenesis of AAU might derive clues from the above as well as from an understanding of the microbiome and possibly from knowledge derived from uveitis in association with Ebola.Although HLA B27-associated uveitis has been recognized since 1973, a variety of recent observations shed new light

2017 Current Opinion in Rheumatology

179. Low-trauma fractures without osteoporosis. (PubMed)

-trauma fractures do not have osteoporosis with DXA (i.e., T-score <-2.5), and some of them have no decreased BMD at all. Some medical conditions (spondyloarthropathies, chronic kidney disease and mineral bone disorder, diabetes, obesity) or drugs (glucocorticoids, aromatase inhibitors) are more prone to cause fractures with subnormal BMD. In the situation of fragility fractures with subnormal or normal BMD, clinicians face a difficulty as almost all the pharmacologic treatments have proved

2017 Osteoporosis International

180. The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis patients (PubMed)

The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis patients Dialysis-related destructive spondyloarthropathy caused by beta-2 microglobulin (β2M) amyloid deposits in intervertebral discs is a major burden for patients undergoing long-term dialysis. This study aimed to quantify the presence of β2M amyloid deposits in the intervertebral disc tissue of such patients and analyze whether there was a significant correlation between β2M

Full Text available with Trip Pro

2017 Journal of orthopaedic surgery and research

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>